GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TheraCryf PLC (LSE:TCF) » Definitions » FCF Margin %

TheraCryf (LSE:TCF) FCF Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is TheraCryf FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TheraCryf's Free Cash Flow for the six months ended in Sep. 2024 was £-1.39 Mil. TheraCryf's Revenue for the six months ended in Sep. 2024 was £0.00 Mil. Therefore, TheraCryf's FCF Margin % for the quarter that ended in Sep. 2024 was 0.00%.

As of today, TheraCryf's current FCF Yield % is -137.90%.

The historical rank and industry rank for TheraCryf's FCF Margin % or its related term are showing as below:

LSE:TCF' s FCF Margin % Range Over the Past 10 Years
Min: -1510.82   Med: -933.94   Max: -756.57
Current: -785.61


During the past 12 years, the highest FCF Margin % of TheraCryf was -756.57%. The lowest was -1510.82%. And the median was -933.94%.

LSE:TCF's FCF Margin % is ranked worse than
72.34% of 1045 companies
in the Biotechnology industry
Industry Median: -145.32 vs LSE:TCF: -785.61


TheraCryf FCF Margin % Historical Data

The historical data trend for TheraCryf's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TheraCryf FCF Margin % Chart

TheraCryf Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1,510.82 - -933.94 -756.57

TheraCryf Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -508.82 -321.21 - -

Competitive Comparison of TheraCryf's FCF Margin %

For the Biotechnology subindustry, TheraCryf's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TheraCryf's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's FCF Margin % distribution charts can be found below:

* The bar in red indicates where TheraCryf's FCF Margin % falls into.



TheraCryf FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

TheraCryf's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=-2.996/0.396
=-756.57 %

TheraCryf's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-1.387/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TheraCryf FCF Margin % Related Terms

Thank you for viewing the detailed overview of TheraCryf's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


TheraCryf Business Description

Traded in Other Exchanges
Address
Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical-stage biotechnology company focused on profitable segments in oncology and neuropsychiatry. The company's lead clinical asset, SFX-01 is a patented form of delivering sulforaphane, which could be used in the treatment of a number of cancers, neurodevelopmental disorders, and other diseases.

TheraCryf Headlines

From GuruFocus

Tcf Financial Corp (TCF) EVP, CFO Brian W Maass Sold $887,338 of Shares

By GuruFocus Research GuruFocus Editor 02-05-2021

New TCF Banking Center Opens on West Seven Mile in Detroit

By Business Wire Business Wire 02-26-2021